Yilifang Biotech.
Shenzhen Yilifang Biote∞>chnology Co., Ltd. was estaβ∞blished in 2013. It is a national high-t&≥←ech enterprise integrating the development, pro₩γ&εduction and sales of preci©<£↔sion medical in vitro diagnostic reag←εφ ents. The companychr(34)s research an¶≠∏Ωd development team consist of scientific res>¶¶∞earchers from top inte≠✘±×rnational institutions and domestic translatioγΩn medical elites, including high-quality talent<  s of national leading talents,<™λ Class B peacock talents, and reserve talent₽↔±s. Targeting existing "pain poin∞✔ts" in the market, Yilifang l>ε∞☆inks with domestic and foreign cγ∑utting-edge technologies↔≠β★ and committed to creating good pro£↔≈ducts that can truly>₹ address the demands form the market.

Product architecture
From the major diseases that the s×♥ ¥ociety needs to solve urgen™✘Ωtly, Yilifang has built products iγ•n four major sectors. It has successfully deve♣★•loped more than 20 Class III in vitro diagnostε★♦σic products, and its products have gradually  β&entered the national registrati ♥£‌on stage.

Yilifang was established in the new era of pre₹>←cision medicine. Sin♦'☆€ce its inception, Yilifa'÷≤ng has been pragmatic and prudent in its wor>∞♥₽k style. It has vigorously coordi ₽✘÷nated development in talent cultivatiεπon, research and development innovatio"£πφn, safety compliance,  ♦δ♣and quality system c•☆onstruction, etc. It has also made initial achi£•evements. In terms of talent→≠'÷ training, a high-quality elite team has been™  created. Among the current m¶≤≥↓embers, about 50% ofα♦ employees have masterchr(34)s degrees, a$♥nd more than 10% have doctoral degrees.Ω®  A platform, a post-doctoral practice and innova$β∏tion base, for sustainably meetin​∑‍¥g the needs of high-end talents-a postdoctoral p↑<↑δractice innovation base has been establishe∞≥★d. On the other hand, Yilifang adheres to t£≠>he idea of quality as the basis σ∑←and regulations as the norm, and has est¶↑"‍ablished a comprehensive system in t↑₹erms of quality and safety, fire£&π↓ safety and environmental pr★β€otection. In terms of technological "δ↕¥ innovation, Yilifang h÷↑δas obtained national, provincial, and mun​♠÷₩icipal department’ recognition and a ≠☆wards at various levels ♥ £through independent research and develo§‌★pment. In 2017, as the only representative of•​ the Shenzhen In vitro £☆×← Diagnostic Reagent Enterα®→γprise Group, it was promoted to the National ✘δInnovation and Entrepreneurshipφ↑∞ Competition.